Life Science Start-Up and Development Awardees
The Life Science Start-up and Development grant is intended to support early-stage companies and innovative researchers to translate promising research into the development of tools, devices, or therapeutics related to cancer. This grant seeks proposals for the research or development of innovative ideas that have the potential to address important needs related to cancer prevention, screening, detection, and treatment to advance cancer care, lessen the burden of cancer, and improve health outcomes.
Cycle 1
May 2023
AI Enabled 3D Spatial Biology of Cancer Biopsies
Alpenglow Biosciences (Principal Investigator: Nicholas Reder MD, MPH)Identification of Novel Targets in a Unique Subset of Tregs for Therapies for Colorectal Cancer
Benaroya Research Institute (Principal Investigator: Kazushige Ninomiya, PhD)Market Validation and Partner Building for Family-Scaling in Hereditary Cancer Prevention
ConnectMyVariant (Principal Investigator: Brian Shirts, MD, PhD)Development of CAR-NK Cells to Treat B-Cell Leukemia Regardless of CD19 Expression
Deverra Therapeutics (Principal Investigator: Colleen Delaney, MD MSc)Development of an Engineered Allogeneic MPS Cell Product for Treatment of Solid Tumors
Deverra Therapeutics (Principal Investigator: Colleen Delaney, MD MSc)Development of a First-in-Class Immunotherapy to Treat Advanced Solid Tumors Through IND-Enabling Safety Studies
Kayothera, Inc (Principal Investigator: Mark Esposito, PhD)A New Paradigm for Autologous and Allogeneic Cell Therapy Manufacturing
Proteios Technology, Inc (Principal Investigator, Bob Snyder, PhD, MBA)Clinical Translation of Novel Pulsed-Power Magnetoporation Device for Improved Cell Therapy Manufacturing of Chimeric Antigen Receptor T (CAR-T) Cells
Sigma Genetics, Inc (Principal Investigator: Zachary Rapp, BA)Delivering Personalized Precision Care to Cancer Patients by Translating Systems Biology to the Clinic
Sygnomics, Inc (Principal Investigator: Nitin Baliga, PhD)Discovery of Targeted Small Molecule MYCN Therapeutics for Neuroblastoma
Talus Bioscience (Principal Investigator: Lindsay Pino, PhD)Therapeutic Disruption of the Rhabdomyosarcoma Transcriptional Core Regulatory Circuit
Talus Bioscience (Principal Investigator: Alex Federation, PhD)Development of Novel Electromagnetic Rewarming Technology for Urgent and Unmet Needs in the Cryopreservation of Therapeutic Cells
University of Washington (Principal Investigator: Dayong Gao, PhD)Development of Pathology Translator to Automate Creation of Patient-Centered Pathology Reports for Cancer Care
University of Washington (Principal Investigator: John Gore, MD, MS)A 3D Ultrasound System for Breast Cancer Detection in Low-Resource Settings
University of Washington (Principal Investigator: Daniel Leotta, PhD)Tumor Burden and Peripheral T Cell Exhaustion in Ovarian Cancer
University of Washington (Principal Investigator: John Liao, MD, PhD)MetaboCore: A Novel Drug Sensitivity Assay for Human Cancer
University of Washington School of Medicine (Principal Investigator: Raymond Yeung, MD)